M Portolani
About
In The Last Decade
M Portolani
41 papers receiving 520 citations
Peers
Comparison fields: 5 of 56
- Oncology 361
- Infectious Diseases 179
- Epidemiology 157
- Electrical and Electronic Engineering 89
- Aerospace Engineering 70
Countries citing papers authored by M Portolani
This map shows the geographic impact of M Portolani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Portolani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Portolani more than expected).
Fields of papers citing papers by M Portolani
This network shows the impact of papers produced by M Portolani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Portolani. The network helps show where M Portolani may publish in the future.
Co-authorship network of co-authors of M Portolani
This figure shows the co-authorship network connecting the top 25 collaborators of M Portolani. A scholar is included among the top collaborators of M Portolani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Portolani. M Portolani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 10 | |
| 3 | 3 | |
| 4 | Giant cell hepatitis following primary infection with HHV-6 variant A, transmitted from the donor, in a liver transplant recipient latently infected with HHV-6 variant B | 1 |
| 5 | 38 | |
| 6 | 8 | |
| 7 | Synthesis, antiviral and antiproliferative activity of some N-benzenesulphonyl-2(2- or 3-pyridylethyl)-benzimidazoles. | 16 |
| 8 | 5 | |
| 9 | 4 | |
| 10 | 24 | |
| 11 | Prevalence of antibodies to human herpesviruses 6 and 7 in early infancy and age at primary infection. | 15 |
| 12 | NEUTRALIZATION OF BOVINE ENTEROVIRUSES BY HUMAN AND ANIMAL SERA. PRELIMINARY CHARACTERIZATION OF A NON-ANTIBODY INHIBITOR PRESENT IN RABBIT SERUM. | 0 |
| 13 | Comparison between immunofluorescence and enzyme-linked-immunosorbent assay in the determination of serum HHV-6 IgG. | 1 |
| 14 | Human papillomavirus DNA detection in Papanicolaou-stained cervical smears with a nonradioactive, in situ hybridization assay. | 3 |
| 15 | 17 | |
| 16 | 5 | |
| 17 | [Infection by BK virus, a human papovavirus, in immunosuppressed children and in children with normal immunological defenses (author's transl)]. | 1 |
| 18 | 42 | |
| 19 | 34 | |
| 20 | 81 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.